Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

Phase 2

Completed

• Conditions: Substance-Related Disorders; Opioid-Related Disorders
• Interventions: Drug: Buprenorphine

• Registration Number: NCT00000318
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.

Detailed Description

Not available

Study Timeline

• Study Start: 1994-12
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Primary Completion: 2004-03
• Study Completion: 2007-08
• Status Verified: 2008-12
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 202

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Arm && Interventions

Group	Intervention	Description
2	Buprenorphine	Maintenance treatment with thrice-weekly medication
1	Buprenorphine	Maintenance treatment with daily medication

Primary Outcome Measures

Name	Time	Method
Opioid and cocaine use	26 weeks
Social and psychological functioning	26 weeks
AIDS risk behavior	26 weeks

Trial Locations

Locations (1)

APT Residential Services Division; 🇺🇸 New Haven, Connecticut, United States